Huiping Li
Roche (Switzerland)(CH)Inner Mongolia Agricultural University(CN)Inner Mongolia University(CN)People 's Hospital of Jilin Province(CN)Shanghai Pulmonary Hospital(CN)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial(2021)378 cited
- → Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study(2019)338 cited
- → Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis(2021)242 cited
- → Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer(2024)191 cited
- → The Brain Renin-Angiotensin System Controls Divergent Efferent Mechanisms to Regulate Fluid and Energy Balance(2010)163 cited
- → MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells